Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Avalo Therapeutics Q2 2024 GAAP EPS $(14.07) May Not Be Comparable To $(6.70) Estimate; Cash On Hand Of Approximately $93.4M As Of June 30, 2024 With Expected Cash Runway Into 2027

Author: Benzinga Newsdesk | August 12, 2024 07:29am

Posted In: AVTX